Araris Biotech
Araris Biotech is a biotechnology platform enables the attachment of any payload to ‘off the shelf’ antibodies.
Total raised
€41M
€40,805,500
Funding rounds
3
Investors
9
distinct backers
Active since
2020-10
latest 2023-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood19
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood19
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €30M+ raised
- ▲ 7y since founding
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-05 | Other | €2.5M | Innosuisse | View deal → |
| 2022-10-04 | Other | €24M | 4BIO Capital,btov Partners,Institute for Follicular Lymphoma Innovation,Pureos Bioventures,Redalpine,Schroders Capital+2 more | View deal → |
| 2020-10-22 | Seed | €14M | Pureos Bioventures | View deal → |
Investors
9Related news
- Araris Biotech Closes $24 Million Financing Roundstartupticker.ch · 2022-10
- finsmes.com
- finsmes.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy